Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

Co-leader of AI-Driven Quant Fund Shares Top Stock Picks and How Individual Investors Can Use AI for Stock Selection

Discover the top stocks that Qraft Technologies' AI-driven quant fund is currently betting on, including Amazon and Meta. Benefit from AI models through ETFs.

MongoDB Atlas Database Service Poised for New Workloads

Discover MongoDB's latest updates and releases for Atlas, now offering improved support for AI, semantic search, dedicated search nodes, and more. Learn how the fully-managed service can elevate your search and stream processing workloads.

Using AI, Google Cloud Aims to Put an End to Money Laundering

Google Cloud's new AML AI tool helps financial institutions detect money laundering more efficiently, reducing alert volumes by over 60% while identifying 2-4x more suspicious activity. Get ahead of ever-changing criminal activity with adaptive, AI-based solutions.

Hugging Face CEO Claims Open Source AI is in Line with American Interests

Discover why Hugging Face CEO is advocating for open source AI. See how it's fostering startups, mitigating biases & promoting copyright for content creators.

Limble Raises $58M to Help Organizations Maintain Physical Assets

Limble raises $58m in funding to provide a platform for businesses to track unconnected physical assets. Its CMMS approach targets a $5.2bn market opportunity.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img